Search Login Register

Histoplasmosis Summary

Description: Infection resulting from inhalation or ingestion of spores of the fungus of the genus HISTOPLASMA, species H. capsulatum. It is worldwide in distribution and particularly common in the midwestern United States. (From Dorland, 27th ed)

Also Known As: Histoplasmoses

Networked: 1105 relevant articles (95 outcomes, 113 trials/studies) for this Disease

Key Drugs and Agents for Histoplasmosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Amphotericin B (Amphotericin) : 23 outcomes 6 studies in 124 results : FDA 12 Generic
  2. Antigens : 15 outcomes 21 studies in 143 results : IBA
  3. Itraconazole (Sporanox) : 12 outcomes 14 studies in 95 results : FDA 6 Generic
  4. Ketoconazole (Nizoral) : 9 outcomes 4 studies in 41 results : FDA 20 Generic
  5. Fluconazole (Zonal) : 8 outcomes 6 studies in 42 results : FDA 41 Generic
  6. Argon : 6 outcomes 7 studies in 19 results : IBA
  7. liposomal amphotericin B : 5 outcomes 3 studies in 16 results : FDA 2
  8. Antibodies : 2 outcomes 4 studies in 57 results : IBA
  9. Krypton : 2 outcomes 4 studies in 10 results : IBA
  10. bevacizumab : 2 outcomes 1 study in 7 results : FDA 2
Show All >>

Diseases Related to Histoplasmosis

  1. Acquired Immunodeficiency Syndrome (AIDS)
  2. Blastomycosis
  3. Coccidioidomycosis
  4. Macular Degeneration (Age-Related Maculopathy)
  5. Infection
Show All >>

Key Therapies for Histoplasmosis

Efficacy Chart >>
  1. Lasers (Laser) : 7 outcomes 13 studies in 41 results
  2. Light Coagulation : 4 outcomes 11 studies in 39 results
  3. Photochemotherapy (Photodynamic Therapy) : 2 outcomes 5 studies in 19 results
  4. Aftercare (After-Treatment) : 2 outcomes 1 study in 11 results
  5. Drug Therapy (Chemotherapy) : 1 outcome in 10 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.